227 related articles for article (PubMed ID: 37789337)
1. Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study.
Fu Y; Li J; Zhu Y; Chen C; Liu J; Gu S; Zheng Y; Li Y
BMC Med Genomics; 2023 Oct; 16(1):232. PubMed ID: 37789337
[TBL] [Abstract][Full Text] [Related]
2. Genetic association and causal relationship between multiple modifiable risk factors and autoimmune liver disease: a two-sample mendelian randomization study.
Gao W; Peng C; Wang Z; Li Y; Liu M
J Transl Med; 2024 May; 22(1):425. PubMed ID: 38704596
[TBL] [Abstract][Full Text] [Related]
3. Association between autoimmune liver diseases and chronic hepatitis B: A multivariable Mendelian randomization study in European population.
Zhang W; Lang R
Prev Med; 2024 Jul; 184():107984. PubMed ID: 38705484
[TBL] [Abstract][Full Text] [Related]
4. Causal effect of autoimmune liver diseases on cancer: Meta-analyses of cohort studies and Mendelian randomization study.
Gu D; Zhang M; Wang Y; Bai Y; Wang X; Deng G
Liver Int; 2022 Oct; 42(10):2216-2226. PubMed ID: 35775855
[TBL] [Abstract][Full Text] [Related]
5. Causal association between autoimmune liver disease and Sjögren's syndrome: A Mendelian randomization study.
Li Y; Wang J; Jiang H; Zhang J; Qi J; Jiang Z; Chen L; Ying Z
Int J Rheum Dis; 2024 May; 27(5):e15151. PubMed ID: 38720573
[TBL] [Abstract][Full Text] [Related]
6. Association between gut microbiota and autoimmune cholestatic liver disease, a Mendelian randomization study.
Cui Y; Guo Y; Kong Y; Zhang G
Front Microbiol; 2024; 15():1348027. PubMed ID: 38601930
[TBL] [Abstract][Full Text] [Related]
7. The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude.
Webb GJ; Ryan RP; Marshall TP; Hirschfield GM
Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2587-2596. PubMed ID: 33493696
[TBL] [Abstract][Full Text] [Related]
8. Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases.
Huang W; Jin T; Zheng W; Yin Q; Yan Q; Pan H; Xu C
J Autoimmun; 2024 May; 145():103188. PubMed ID: 38458076
[TBL] [Abstract][Full Text] [Related]
9. Causal associations between gut microbiota and Cholestatic liver diseases: a Mendelian randomization study.
Yang J; Ma G; Wang K; Yang H; Jiang S; Fan Q; Zhou X; Guo G; Han Y
Front Med (Lausanne); 2024; 11():1342119. PubMed ID: 38327703
[TBL] [Abstract][Full Text] [Related]
10. A bidirectional two-sample Mendelian randomization using the gut microbiota to reveal potential therapeutic targets for primary sclerosing cholangitis.
Liang X; Wang Z; Shu Q; Huang X; Wang J; Wu J; Liu N; Xie N
Eur J Gastroenterol Hepatol; 2024 Feb; 36(2):147-154. PubMed ID: 38131422
[TBL] [Abstract][Full Text] [Related]
11. Genetic predisposition of the gastrointestinal microbiome and primary biliary cholangitis: a bi-directional, two-sample Mendelian randomization analysis.
Luo X; You X
Front Endocrinol (Lausanne); 2023; 14():1225742. PubMed ID: 37900141
[TBL] [Abstract][Full Text] [Related]
12. HLA, gut microbiome and hepatic autoimmunity.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
Front Immunol; 2022; 13():980768. PubMed ID: 36059527
[TBL] [Abstract][Full Text] [Related]
13. Leveraging pQTL-based Mendelian randomization to identify new treatment prospects for primary biliary cholangitis and primary sclerosing cholangitis.
Dai L; Ye Y; Mugaany J; Hu Z; Huang J; Lu C
Aging (Albany NY); 2024 May; 16(10):9228-9250. PubMed ID: 38809509
[TBL] [Abstract][Full Text] [Related]
14. Genetic link between primary sclerosing cholangitis and thyroid dysfunction: a bidirectional two-sample Mendelian randomization study.
Zhang W; Lang R
Front Immunol; 2023; 14():1276459. PubMed ID: 37928559
[TBL] [Abstract][Full Text] [Related]
15. Implications of gut microbiota in autoimmune liver diseases.
Qian Q; He W; Tang R; Ma X
Minerva Gastroenterol (Torino); 2023 Mar; 69(1):95-106. PubMed ID: 33793160
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune liver disease, autoimmunity and liver transplantation.
Carbone M; Neuberger JM
J Hepatol; 2014 Jan; 60(1):210-23. PubMed ID: 24084655
[TBL] [Abstract][Full Text] [Related]
17. Trends in liver transplantation for autoimmune liver diseases: a Canadian study.
Murillo Perez CF; Ivanics T; Claasen MPAW; Yoon P; Wallace D; Selzner N; Hirschfield GM; Hansen BE; Sapisochin G
Can J Surg; 2022; 65(5):E665-E674. PubMed ID: 36223935
[TBL] [Abstract][Full Text] [Related]
18. How genetic risk contributes to autoimmune liver disease.
Ellinghaus D
Semin Immunopathol; 2022 Jul; 44(4):397-410. PubMed ID: 35650446
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome and risk of ischaemic stroke: a comprehensive Mendelian randomization study.
Meng C; Deng P; Miao R; Tang H; Li Y; Wang J; Wu J; Wang W; Liu S; Xia J; Lu Y
Eur J Prev Cardiol; 2023 May; 30(7):613-620. PubMed ID: 36799937
[TBL] [Abstract][Full Text] [Related]
20. Biliary features in liver histology of children with autoimmune liver disease.
Di Giorgio A; D'Adda A; Marseglia A; Sonzogni A; Licini L; Nicastro E; D'Antiga L
Hepatol Int; 2019 Jul; 13(4):510-518. PubMed ID: 31069759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
